Health
Longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels: Study – India TV News
A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune…
A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found. The study, led by the University of Oxford, in collaboration with the Universities of Birmingham,…
Continue Reading
-
General13 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General14 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News23 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General13 hours agoOf saints and sinners | The Spectator Australia